Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma

Ähnliche Einträge

• The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas
  von: Rosario, Maximillian, et al.
  Veröffentlicht: (2014)
• Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells
  von: Xu, Wenxin, et al.
  Veröffentlicht: (2014)
• Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
  von: Xu, Wenxin, et al.
  Veröffentlicht: (2014)
• Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model
  von: Chen, Xiaoyue, et al.
  Veröffentlicht: (2015)
• Comparison of the super agonist complex, ALT-803, to IL-15 as cancer immunotherapeutics in animal models
  von: Rhode, Peter R., et al.
  Veröffentlicht: (2015)